|
|
||||||||



,
* Department of Pediatrics,
Department of Microbiology and Immunology, and
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461; and
Department of Cell Biology and Immunology, Vrije Universiteit, Amsterdam, The Netherlands
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
AM from mice, rats, and humans are able to ingest C. neoformans (8, 9, 10). Optimal phagocytosis of encapsulated C. neoformans by AM occurs in the presence of opsonin (either serum or Ab) and may be associated with macrophage-mediated killing of C. neoformans. However, ingestion may also be accompanied by intracellular fungal replication in vitro and in vivo (11). In vitro experiments suggest that the activation state of macrophages is an important determinant of their anticryptococcal activity. Thus, in the appropriate context, AM may limit the early growth of C. neoformans and prevent extrapulmonary dissemination. Alternatively, AM may serve as a site for evasion from the normal host response and promote C. neoformans replication.
Both rats and mice have been used to study the pathogenesis of pulmonary cryptococcosis. Nevertheless, these two species differ widely in their susceptibility to pulmonary cryptococcal infection. Rats are significantly more resistant to pulmonary cryptococcosis than mice and typically develop localized subclinical pulmonary infection (2). To better understand these discrepancies in host susceptibility as they relate to macrophage function, we compared the effects of AM depletion on pulmonary cryptococcal infection using liposome clodronate. Additional studies analyzed host species differences in anticryptococcal activity, including phagocytic activity, ability to limit intracellular C. neoformans growth, and susceptibility to C. neoformans-induced lysis. The results indicate that functional differences between mouse and rat macrophages may have profound consequences on the outcome of cryptococcosis in these animals.
| Materials and Methods |
|---|
|
|
|---|
Male Fischer, Sprague-Dawley, and female Brown Norway (BN) rats, weighing 200250 g, were obtained from Harlan Sprague-Dawley. This weight corresponds to an age of 6 -11 wk depending on the rat strain. Six- to 8-wk-old female BALB/c and A/J mice were obtained from the National Cancer Institute). C57BL/6 mice were obtained from The Jackson Laboratory. Animals were cared for in accordance with the institutional animal care and use committee of Albert Einstein College of Medicine of Yeshiva University.
C. neoformans
For animal studies, American Type Culture Collection strain 24067 was used. This is a serotype D strain that has been studied extensively studied in mouse and rat models of cryptococcosis (2, 12). This strain, also known as 52D, has been used in other laboratories that study the pathogenesis of pulmonary infection (13). The organism was grown in Sabourauds dextrose broth (BD Biosciences) at 30°C for 3 days, then washed three times with PBS, pH 7.4, and suspended in PBS for infection. For in vitro experimentation, two strains of C. neoformans were studied, H99 (a serotype A strain) and 24067.
AM depletion
Dichloromethylene bisphosphonate (CL2MBP) or clodronate was a gift from Roche and was encapsulated in liposomes as described previously (14). CL2MBP selectively depletes AM after intratracheal instillation (14). Of note, intratracheal administration of liposomal clodronate does not appear to affect lung dendritic cell density (15, 16). Nevertheless, variable effects (depletion, partial depletion, and nondepletion) on splenic dendritic cells after i.v. administration of liposomal clodronate have been reported (17, 18, 19). To confirm the adequacy of AM depletion, rats, five per group, were given 0.8 ml of PBS liposomes or CL2MBP liposomes intratracheally. Three days later, lungs were removed and frozen. Lung sections were stained for the presence of AM using an FITC-conjugated Ab (ED1; Serotec) that specifically recognizes macrophages (20). For mice, the adequacy of AM depletion was confirmed after administration of 0.1 ml of PBS liposomes or CL2MBP liposomes by either the intranasal or intratracheal route. Three days later, lung tissue was removed and frozen. Sections were stained using biotin-labeled Ab specific for MAC-3 (BD Pharmingen). Biotinylated Ab was then detected with avidin conjugated to HRP, and color was detected with diaminobenzidine. Fischer rats and mice (A/J, BALB/C) treated with liposome clodronate had no detectable macrophage staining (not shown). Intranasal liposome clodronate (A/J) and intratracheal liposome clodronate (BALB/c) treatments gave similar results with regard to AM depletion. For depletion studies, animals were given clodronate liposome or PBS liposome by intratracheal or intranasal administration at the doses described above and then infected 3 days later. To insure ongoing depletion of AM, repeat intratracheal/intranasal injections of liposome clodronate were given weekly (14).
Infection
Rats were anesthetized by exposure to isoflurane and were infected with 1 x 107 C. neoformans in 0.3 ml of PBS. C. neoformans administration was performed intratracheally, as described previously (2). In other experiments, rats were intratracheally infected with 1 x 105 C. neoformans. Mice were anesthetized by i.p. injection with ketamine (10 mg/kg) and xylazine (125 mg/kg) in PBS. The trachea was surgically exposed, and mice were inoculated intratracheally with 1 x 104 C. neoformans cells in 0.05 ml of PBS. The smaller inoculum was used for murine studies, because of the enhanced susceptibility of mice to cryptococcal infection. To determine the effects of liposome-clodronate treatment without infection, rats or mice were given sham infection (i.e., PBS alone).
Fungal burden
Groups of animals were killed at various times after infection, and lungs and spleens were removed. Left lungs were finely minced in 5 ml (for rats) and 2 ml (for mice) of PBS with a protease inhibitor mixture (Complete Mini; Roche) and further homogenized by treatment with a Tissue Terrator (Biospec Products). Serial dilutions were plated on Sabourauds dextrose agar. To ensure that liposome clodronate had no direct effect on C. neoformans growth, organisms were incubated in Sabourauds dextrose broth containing 10% liposome clodronate. At various times (2, 4, 6, 9, and 24 h), an aliquot of culture was removed and tested for C. neoformans growth. No differences in growth were observed.
Histology and immunohistochemistry
For rats, right lungs were immersed in O.C.T. compound (Sakura Finetec), snap-frozen, cut into 5-µm-thick sections, and fixed in methanol. Sections were stained with H&E. For glucuronoxylomannan (GXM) immunohistochemistry, sections were treated with 0.3% H2O2 for 30 min, followed by 10% goat serum in PBS for 1 h. The primary Ab was a murine IgG1, 18B7, at a concentration of 10 µg/ml (21). Primary Ab was detected by peroxidase-conjugated, goat anti-mouse isotype-specific IgG (Southern Biotechnology Associates), and color was developed with diaminobenzidine. For mice, lungs were processed in a similar manner.
Cytokine/chemokine measurements
Lung homogenates were centrifuged, and supernatants were frozen at 20°C. Levels of IL-4, IL-10, IL-1
, IL-1R antagonist (IL-1RA), TNF-
, IFN-
, TGF-
1, MIP-2, and MCP-1 were measured in rat lung homogenates using commercially available ELISA kits (BD Pharmingen and BioSource International). Levels of IL-10, TNF-
, IFN-
, IL-1
, TGF-
1, and MCP-1 were measured in murine lung homogenates using commercially available ELISA kits (BD Pharmingen).
Bronchoalveolar lavage
Rats and mice were killed by asphyxiation with CO2, and their tracheas were cannulated with angiocaths (BD Biosciences). Lungs were lavaged (five times for rats and 10 times for mice) with sterile HBSS without phenol red (Invitrogen Life Technologies) with 1 mM EGTA (Sigma-Aldrich). Lavage fluids were pooled, and cells were collected by centrifugation. RBC were lysed by incubation in 0.17 M NH4Cl at 4°C for 10 min. Cells were washed with HBSS and resuspended in DMEM (Invitrogen Life Technologies) with 10% heat-inactivated FCS (Bioproducts for Science). Approximately 1 x 106 AM were obtained per rat and 1 x 105 AM per mouse.
Cell size
Cells were lavaged from Fischer rats and BALB/c mice, suspended at 3 x 104/ml, and subjected to centrifugation using a cytospin (Thermo Shandon) at 800 rpm for 6 min. Cells were fixed with ice-cold methanol and stained using a Wright stain. Approximately 150200 cells/slide were counted under x1000 magnification. Pictures were taken with a QI Imaging Retiga 1300 digital camera using the Q Capture Suite version 2.46 software (Q Imaging Burnaby). The longest diameter of cells was determined in pixels and then converted into microns using a standard grid of known size. Pictures were processed in Adobe Photoshop 7.0 for Windows.
Opsonins
Both sera and Ab against the cryptococcal polysaccharide were used as opsonins. To obtain sera, animals were bled immediately before lavage. Sera were stored at 4°C and used within 34 h of being obtained. For Ab studies, the murine IgG1, 18B7, was used (21).
Phagocytosis assay
AM were obtained from Fischer rats and BALB/c mice. Cells were plated in 96-well tissue culture plates (Costar) at a density of 2.5 x 104/well in 0.2 ml of DMEM-10% FCS and allowed to attach at 37°C. Medium was replaced with fresh medium containing 2.5 x 104 C. neoformans (E:T cell ratio, 1:1) alone or with 10% serum (rat or mouse) or mAb 18B7 (10 µg/ml). Cells were incubated together for 4 h and washed twice with fresh medium. The total number of internalized C. neoformans per total number of macrophages was calculated. Approximately 200300 AM/well were counted.
Transmission electron microscopy (TEM)
AM were harvested from Fischer rats and BALB/c mice. Approximately 1 x 106 cells/well were placed in a six-well plate. Cells were incubated with C. neoformans (1 x 106 organisms/well) in the presence of mAb 18B7 (10 µg/ml) for 2 h. The supernatant was then removed, and cells were fixed with 2.5% glutaraldehyde with 0.1 M cacodylate, then placed in buffer containing 0.1 M cacodylate. Cells were visualized with a JEOL 1200 EX transmission electron microscope.
Intracellular growth
AM from Fischer rats and BALB/c mice were allowed to phagocytize C. neoformans in the presence of mAb 18B7 or serum (see phagocytosis assay). At 4 h, cultures were washed and returned to the incubator. At various times (4, 8, 16, and 24 h) after inoculation of C. neoformans, cells were fixed with cold methanol and stained with Giemsa. The total number of internalized C. neoformans per total number of phagocytic AM was determined. Approximately 200300 AM/well were counted.
The results of these studies were confirmed by measuring changes in fungal burden. For these studies, AM from Fischer rats and BALB/c mice were incubated with C. neoformans at a T:E cell ratio of 1:5 in the presence of mAb 18B7 (10 µg/ml) or medium alone. Four hours after coincubation, supernatants were removed, and cells were lysed with water for 1 h at room temperature. Both fractions (i.e., supernatant and lysate) were plated on Sabourauds dextrose agar. For some cultures, supernatants were removed at 4 h (to remove noninternalized organisms), and cell cultures were returned to the incubator for an additional 20 h. In separate experiments, both H99 and 24067 strains of C. neoformans were studied.
Imaging of fungal-macrophage interaction
Visualization of live interactions between C. neoformans (American Type Culture Collection 24067) and primary macrophages was performed with an Olympus IX70 microscope with a x40 UPlanFL N.A. 0.50 phase 1 objective with an N.A. 0.5 condenser. The halogen lamp was shuttered for each exposure with a Uniblitz shutter (Vincent Associates). The microscope was housed in a Plexiglas box, and temperature was stabilized at 37°C with a forced air heater system. Additionally, 5% CO2 bubbled through water was delivered to a chamber locally at the culture dish. Images were collected with a Cooke Sensicam HQ run by I. P. Lab (Scanalytics) on a Dell PC with Windows XP. Images for the intracellular replication were collected at 1-min intervals with the x40 objective. Animations were created using ImageJ software (W. S. Rasband, National Institutes of Health, Bethesda, MD).
Nitrogen and oxygen free radical production
AM were obtained by lavage from both Fischer rats and BALB/c mice. To measure oxygen free radical production, luminescence studies were performed. Briefly, cells were washed with HBSS and resuspended at a density of 5 x 105/ml in HBSS containing 50 µM Luminol (sodium salt; Sigma-Aldrich) and C. neoformans (2.5 x 106/ml) opsonized with 18B7 (10 µg/ml). Cell suspensions were placed in a luminometer (Monolight 2010; Analytical Luminescence Laboratory). Measurements were obtained within minutes of adding opsonized organisms (time zero) and every 10 min for 1 h. Luminescence readings minus the readings obtained from macrophages in Luminol solution alone were determined. Cultures were performed in triplicate. To assay for nitrogen free radical production, nitrite concentrations in culture supernatants were determined as previously described (22). Approximately 4 x 104 AM from Fischer and BALB/C mice were placed in DMEM and then incubated overnight at 37°C. The following day, mAb opsonized C. neoformans (American Type Culture Collection 24067) were added to cultures. At various times (48, 72, and 96 h), supernatants were tested for the presence of nitrite using the Greiss reagent.
To determine the role of free oxygen free radical production in the enhanced ability of rat AM to limit C. neoformans growth, intracellular growth experiments were performed as described above, but catalase (200 µg/ml) or superoxide dismutase (40 µg/ml; both from Sigma-Aldrich) were added to rat and mouse AM cultures at the same time that mAb and C. neoformans were added. Fungal burdens in supernatants and lysates were determined at 24 h.
Lysozyme production
Approximately 1 x 105 primary rat and mouse AM were seeded into 96-well plates and allowed to adhere. Medium was then replaced with medium containing mAb 18B7 and C. neoformans (1 x 105 cells/well). Supernatants were removed at 5 h and tested for lysozyme using Micrococcus lysodeikticus as previously described (23). Briefly, 40 µl of a 0.03% suspension of bacteria in 0.1 M potassium phosphate buffer (pH 6.2) was added to 200 µl of supernatant or lysozyme standard (Roche) and incubated at 37°C for 30 min. Absorbance at 450 nm was then determined.
Statistics
For single comparisons between groups, Students t test was performed. For multiple comparisons between single groups, a one-way ANOVA was performed. For post-hoc analysis, data were compared was using Dunnetts test if multiple comparisons against a control were made. Otherwise, the Student-Newman-Keuls test was used. A value of p < 0.05 was considered significant. Statistics were calculated using SPSS Base 10.
| Results |
|---|
|
|
|---|
AM-depleted Fischer rats infected with C. neoformans had 3- to 6-fold higher lung fungal burden at all times tested (i.e., days, 3, 14, and 28; Fig. 1A) compared with normal rats. Spleen fungal burden was also increased on day 3 of infection in AM-depleted animals compared with controls, consistent with increased extrapulmonary dissemination (not shown). For both Sprague Dawley and BN rats, increases in lung fungal burden (2.5- and 11-fold, respectively) were observed in association with AM depletion on day 3 of infection (the only observation time; Fig. 1, B and C). AM depletion also resulted in an increase in fungal burden for Sprague-Dawley rats infected with a lower inoculum (105) of C. neoformans. In these experiments, lung fungal burden for AM-depleted and nondepleted animals were 255 ± 93 x 104 vs 23 ± 9 x 104, respectively (p < 0.01). For A/J mice, lung fungal burden was similar for AM-depleted and control animals on day 3 (1.36 ± 0.32 x 106 vs 1.49 ± 0.74 x 106; Fig. 1D), but was
2-fold lower in AM-depleted animals on day 14 (7.9 ± 0.37 x 106 vs 17.0 ± 0.57 x 106; p < 0.001). For BALB/c mice, AM depletion was associated with a decrease in lung fungal burden at both 3 days (
2.8-fold; p = 0.002) and 14 days (
4-fold; p < 0.001; Fig. 1E). For C57/BL6 mice, AM depletion was associated with an
13-fold decrease in lung fungal burden on day 3 (the only observation time; p = 0.003; Fig. 1F). In summary, AM depletion in all three rat strains tested resulted in increased lung fungal burden, whereas AM depletion in all three mouse strains resulted in either no change or a decrease in lung fungal burden.
|
|
|
|
For Fischer rats, we measured the lung levels of IFN-
, IL-1
, IL-1RA, IL-4, IL-10, TNF-
, and TGF-
1. We also measured levels of MCP-1 (CCL2) and MIP-2 (CXCL2). IL-1
and IL-RA lung levels increased over the course of infection for both AM-depleted and control rats, with maximal levels on day 28 (see Table I, Fischer rat cytokine and chemokine levels). Compared with controls, AM-depleted animals exhibited lower levels of IL-1
on day 28 and higher levels of IL-1RA on both days 3 and 28 of infection. IL-10 levels for AM-depleted rats were lower on day 3, but higher on day 14 compared with controls. IFN-
and TNF-
increased over the course of infection for both AM-depleted and control rats, with maximal levels on day 28. Nevertheless, no differences in IFN-
and TNF-
levels were observed between AM-depleted and control rats. No differences in IL-4 (not shown) and TGF-
1 levels were detected between AM-depleted and control rats. Both MCP-1 and MIP-2 levels were generally higher in AM-depleted animals compared with controls.
|
, IL-10, TNF-
, TGF-
1, and MCP-1 (see Table I, A/J mouse cytokine and chemokine levels). Compared with control mice, lung levels of IL-1
were higher in AM-depleted mice on day 14 of infection, whereas both IL-10 and TNF-
levels were lower on day 14 of infection for AM-depleted mice. TGF-
1 levels were lower on day 3 of infection for AM-depleted animals compared with controls. MCP-1 levels were higher in AM-depleted mice on both days 3 and 14. Interaction of AM and yeast cells in vitro
To better understand the basis for the disparate effects of AM depletion in rats and mice, we performed in vitro studies to identify potential differences in anticryptococcal activity between rat and mouse AM. We noted species-associated differences in macrophage size by light microscopy, with AM from Fischer rats being larger than AM from BALB/c mice. The longest diameter of AM from rats was greater than that of AM from mice (23.0 ± 14 vs 16.6 ± 2.3 µm; p < 0.001).
Incubation of rat and mouse AM with C. neoformans H99 in the presence of mAb 18B7 resulted in phagocytosis of yeast cells. At 4 h, the phagocytic index was considerably greater for rat AM than for mouse AM (Fig. 5). Serum-mediated phagocytosis of C. neoformans was more efficient for rat AM than mouse AM, although the overall amount of phagocytosis was considerably lower than that observed when capsule-binding mAb was used as the opsonin. No detectable intracellular C. neoformans were detected for mouse AM that had been cocultured with serum-opsonized C. neoformans. Similar results were observed with strain 24067 as noted for H99, for both Ab and serum-mediated phagocytosis. The overall efficiency of serum-mediated phagocytosis was lower for strain 24067 for both rat and mouse AM (not shown). All phagocytosis experiments were performed at least twice with similar results.
|
|
To study intracellular replication of C. neoformans, three types of experiments were performed. In the first study, the number of intracellular organisms was counted at various times after organisms had been ingested. These observations revealed a progressive increase in the number of organisms inside mouse AM, so that by 24 h the numbers of C. neoformans inside murine macrophages had increased by 3-fold (Fig. 7A). Because extracellular organisms were removed by washing, we conclude that the increase in intracellular numbers reflects intracellular growth. In contrast, the number of C. neoformans inside rat macrophages remained relatively constant (Fig. 7A). Similar results were obtained using 10% serum from mouse and rats as opsonin (not shown). These experiments were performed twice with similar results.
|
2.2-fold) for rat AM cultures than for mouse AM cultures (Fig. 7B). These findings are consistent with our microscopic studies, which indicated enhanced phagocytic activity of rat AM. By 20 h, the fungal burden of lysates for mouse AM cultures had increased greatly and was greater (
1.9-fold) than the fungal burden of lysates from rat AM cultures. Also, at 20 h the fungal burden of supernatants for mouse AM cultures was 2.5-fold greater than that for rat AM cultures (84,750 ± 22,273 vs 38,500 ± 6,000). As with our counting experiments, extracellular organisms were removed at 4 h by washing. As a result, minimal to no organisms were present in the supernatants of cultures at 20 h when opsonin was not used (not shown). Thus, we suspect that organisms found in the supernatants at 20 h originate from an intracellular site. This experiment was repeated with strain H99 with similar results. To confirm our in vitro studies suggesting that rat AM were more efficient in limiting intracellular growth of C. neoformans than mouse AM, we performed live imaging studies in which we focused on a single field and recorded the outcome of macrophage infection for 15 h (see supplemental video).4 For mouse AM, intracellular budding of C. neoformans was noted in five of six macrophages. Furthermore, all infected macrophages lysed by the end of 900 min, with most cells containing many C. neoformans at the time of lysis, indicating multiple replications. In contrast, intracellular budding of C. neoformans was noted in only two of nine rat AM (p = 0.04), with one macrophage containing a C. neoformans that underwent a single budding. Lysis was noted in only two of nine rat AM. At the time of lysis, both cells contained only a single organism. Imaging studies were performed twice for both rat and mouse cells with similar results
Oxidative burst, and NO and lysozyme production
To determine the basis of the enhanced anticryptococcal activity of rat AM, we measured oxygen and nitrogen free radical production by rat and mouse AM after Ab-mediated phagocytosis of C. neoformans. In the context of mAb-mediated phagocytosis of C. neoformans, oxidative burst occurred earlier for rat AM than for mouse AM (see Fig. 8A). Furthermore, the magnitude of this burst was 7- to 17-fold higher for rat AM than for mouse AM. There was no increase in nitrite levels in the supernatant of rat or mouse AM cultures up to 4 days after Ab-mediated phagocytosis of C. neoformans (not shown).
|
Lysozyme levels were higher in the supernatants of rat macrophage cultures compared with mouse cultures. In the absence of infection, there was no detectable lysozyme (limit of detection, 10 ng/ml) in the supernatant of mouse AM cultures, whereas the average concentration in rat AM cultures was 1694 ± 481 ng/ml. For infected macrophage cultures, the average lysozyme concentrations was
6-fold greater for rat macrophages compared with mouse AM (Fig. 9). Experiments were performed twice, with similar results.
|
| Discussion |
|---|
|
|
|---|
AM depletion of mice resulted in reduced lung fungal burden, whereas AM depletion of rats resulted in increased lung fungal burden and extrapulmonary dissemination. These results correlate with enhanced resistance to pulmonary cryptococcal infection in rats compared with mice, even though rats had to be infected with 100-fold more inocula than mice on a weight basis because these animals are so resistant to C. neoformans infection.
Our findings suggest that differences in anticryptococcal activity among AM from rats and mice correlate with species susceptibility. We note that our studies used three strains of mouse and three strains of rat; consequently, the results are more likely to reflect species differences than variation in intraspecies strain susceptibility. AM appear to play a protective role for rats against cryptococcal infection, but a disease-enhancing role in mice. In support of this idea, we found that rat AM demonstrated enhanced anticryptococcal activity compared with mouse AM, as manifested by increased phagocytosis, enhanced control of intracellular growth, and increased resistance to pathogen-induced cell lysis. The basis for increased effector activity of rat AM compared with that in mice appears to involve both oxidative and nonoxidative mechanisms. These findings are consistent with previous observations noting differences in rat and mouse AM biology (26, 27, 28, 29).
Feldmesser et al. (1) noted a 5-fold higher budding index for intracellular C. neoformans compared with extracellular C. neoformans during pulmonary infection in mice. This observation and our finding of rapid intracellular replication of C. neoformans in mouse AM resulting in lysis of the host cells suggested that C. neoformans may be able to use the murine AM as a site for enhanced replication. Hence, we hypothesized that macrophage depletion could enhance host defense in the mouse by removing a favorable replication site. Consistent with this hypothesis, depletion of AM in mice resulted in reduced fungal burden. In contrast, the rat AM is intrinsically more active against C. neoformans, and depletion of these sites results in increased C. neoformans growth.
The ability of rat AM to limit intracellular C. neoformans growth and resist pathogen-mediated lysis correlated with enhanced oxidative and nonoxidative activities. These studies were performed with AM from normal noninfected rats in the absence of exogenous cytokine stimulation and would appear to highlight intrinsic differences between rat and mouse AM. Oxidative killing of C. neoformans is an important mechanism of action for immune effector cells (30, 31). Rat AM incubated with catalase and superoxide dismutase showed an increase in cryptococcal lysate fungal burden, suggesting the importance of H2O2 and reactive oxygen intermediates in limiting intracellular growth. In contrast, mouse AM failed to show an increase in lysate fungal burden after a similar treatment. Compared with murine AM, rat AM also demonstrated higher levels of lysozyme in culture supernatants. Lysozyme has been shown to have potent anticryptococcal activity (32).
Depletion of AM in both rats and mice (all strains tested) resulted in increased inflammation compared with nondepleted animals. Increased inflammation was present in the context of increased (rats) and decreased (mice) C. neoformans numbers within the lung. This suggests a conserved role for AM in limiting inflammation in both species. These findings are consistent with the known anti-inflammatory properties of AM, which include production of anti-inflammatory cytokines, phagocytosis of apoptotic cells, and modulation of lymphocyte proliferation. In addition, enhanced function of dendritic cells in the context of AM depletion has been described (16). In keeping with the increase in pulmonary inflammation, we found increased chemokine (MCP-1 and CCL-2) expression in the lungs of both rats and mice depleted of AM. Altered cytokine expression was also present in association with AM depletion, although no specific change in Th-type profile (i.e., Th1 vs Th2) was detected for either mice or rats. A decrease in IL-10 levels was observed in both mouse and rat lungs, and this may reflect a decrease in AM IL-10 production. It may also account for the increased inflammation in association with AM depletion.
Our findings have important implications for understanding the relative importance of innate and adaptive immunities in cryptococcal infection. Previous experiments in mice have highlighted the importance of Th polarization with regard to susceptibility to infection, with enhanced susceptibility to infection linked to Th2 polarization (33). Interestingly, Th2 polarization has not been associated with enhanced susceptibility to cryptococcal infection in rats (34). Based on our studies, we hypothesize that the relative importance of Th polarization to the host response to cryptococcal infection may be dependent on the anticryptococcal activity of the innate immune response, including the ability of AM to limit the initial extent of infection. Thus, for the rat, in which AM are inherently more active against C. neoformans, the relative importance of Th polarization to host defense may be lower. In contrast, for mice, the importance of Th polarization may be considerably greater because of the relatively weak anticryptococcal activity of murine AM.
In summary, our study suggests that the differences in susceptibility to pulmonary cryptococcal infection in rats and mice may result from basic differences in AM-C. neoformans interactions that exist between rats and mice. Enhanced resistance of rats to pulmonary cryptococcal infection correlates with increased anticryptococcal activity of rat AM that involves both oxidative and nonoxidative mechanisms. In contrast, the enhanced susceptibility of mice to cryptococcal infection correlates with a more permissive or disease-enhancing role for AM. Our studies point to important basic differences in the host response to pulmonary fungal infections that occur between animal types and serve as a caution for extrapolating results from one animal system to another.
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by National Institutes of Health Grants AI033142-11, AIO33774-11, AIO52733-02, HL059842-08, and GM071421-01 (to A.C.) and HL064547-05 (to D.L.G.). ![]()
2 Address correspondence and reprint requests to Dr. David L. Goldman, Albert Einstein College of Medicine, Forchheimer 702, 1300 Morris Park, Bronx, NY 10461. E-mail address: dgoldma{at}aecom.yu.edu ![]()
3 Abbreviations used in this paper: AM, alveolar macrophage; BN, Brown Norway; CL2MBP, dichloromethylene bisphosphonate; IL-1RA, IL-1R antagonist; TEM, transmission electron microscopy; GXM, glucuronoxylomannan. ![]()
4 The online version of this article contains supplemental material. ![]()
Received for publication March 4, 2005. Accepted for publication June 15, 2005.
| References |
|---|
|
|
|---|
-stimulated murine macrophage-like J774.16 cells. J. Leukocyte Biol. 57:657.-662. [Abstract]
This article has been cited by other articles:
![]() |
P.-Y. Cheng, A. Sham, and J. W. Kronstad Cryptococcus gattii Isolates from the British Columbia Cryptococcosis Outbreak Induce Less Protective Inflammation in a Murine Model of Infection than Cryptococcus neoformans Infect. Immun., October 1, 2009; 77(10): 4284 - 4294. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Osterholzer, J. E. Milam, G.-H. Chen, G. B. Toews, G. B. Huffnagle, and M. A. Olszewski Role of Dendritic Cells and Alveolar Macrophages in Regulating Early Host Defense against Pulmonary Infection with Cryptococcus neoformans Infect. Immun., September 1, 2009; 77(9): 3749 - 3758. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ma, F. Hagen, D. J. Stekel, S. A. Johnston, E. Sionov, R. Falk, I. Polacheck, T. Boekhout, and R. C. May The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation PNAS, August 4, 2009; 106(31): 12980 - 12985. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stenzel, U. Muller, G. Kohler, F. L. Heppner, M. Blessing, A. N.J. McKenzie, F. Brombacher, and G. Alber IL-4/IL-13-Dependent Alternative Activation of Macrophages but Not Microglial Cells Is Associated with Uncontrolled Cerebral Cryptococcosis Am. J. Pathol., February 1, 2009; 174(2): 486 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Chiapello, J. L. Baronetti, A. P. Garro, M. F. Spesso, and D. T. Masih Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway Int. Immunol., December 1, 2008; 20(12): 1527 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guillot, S. F. Carroll, R. Homer, and S. T. Qureshi Enhanced Innate Immune Responsiveness to Pulmonary Cryptococcus neoformans Infection Is Associated with Resistance to Progressive Infection Infect. Immun., October 1, 2008; 76(10): 4745 - 4756. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-h. Chen, D. A. McNamara, Y. Hernandez, G. B. Huffnagle, G. B. Toews, and M. A. Olszewski Inheritance of Immune Polarization Patterns Is Linked to Resistance versus Susceptibility to Cryptococcus neoformans in a Mouse Model Infect. Immun., June 1, 2008; 76(6): 2379 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Mizgerd and S. J. Skerrett Animal models of human pneumonia Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L387 - L398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Kechichian, J. Shea, and M. Del Poeta Depletion of Alveolar Macrophages Decreases the Dissemination of a Glucosylceramide-Deficient Mutant of Cryptococcus neoformans in Immunodeficient Mice Infect. Immun., October 1, 2007; 75(10): 4792 - 4798. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zaragoza, M. Alvarez, A. Telzak, J. Rivera, and A. Casadevall The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response Infect. Immun., June 1, 2007; 75(6): 2729 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shea, T. B. Kechichian, C. Luberto, and M. Del Poeta The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect. Immun., October 1, 2006; 74(10): 5977 - 5988. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-A. Pirofski Of Mice and Men, Revisited: New Insights into an Ancient Molecule from Studies of Complement Activation by Cryptococcus neoformans. Infect. Immun., June 1, 2006; 74(6): 3079 - 3084. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |